Heska (NASDAQ: HSKA)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-03 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | 0.340 | 0.3700 | ||||
REV | 68.580M | 64.677M | -3.903M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Heska (NASDAQ: HSKA) through any online brokerage.
Other companies in Heska’s space includes: SI-BONE (NASDAQ:SIBN), Varex Imaging (NASDAQ:VREX), AngioDynamics (NASDAQ:ANGO), Butterfly Network (NYSE:BFLY) and Cardiovascular Systems (NASDAQ:CSII).
The latest price target for Heska (NASDAQ: HSKA) was reported by Piper Sandler on Tuesday, August 16, 2022. The analyst firm set a price target for 170.00 expecting HSKA to rise to within 12 months (a possible 77.55% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Heska (NASDAQ: HSKA) is $95.75 last updated Today at August 18, 2022, 4:45 PM UTC.
A quarterly cash dividend of $0.10 per share of Class A Common Stock. The quarterly cash dividend was payable on October 10, 2012 to stockholders of record on September 26, 2012.
Heska’s Q3 earnings are confirmed for Thursday, November 3, 2022.
There is no upcoming split for Heska.
Heska is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.